Neuropsychiatric symptoms and brain structural alterations in Fabry disease

European Journal of Neurology

Volumn 18, Issue 2, 2011, Pages 347-353

  Schermuly, I ^a   Muller M J ^a   Muller K M ^a   Albrecht, J ^a   Keller, I ^a,b   Yakushev, I ^a   Beck, M ^c   Fellgiebel, A ^a  

^a Department of Psychiatry and Psychotherapy ^*  (Germany)

^b Institute of Neuroradiology   (Germany)

^c UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Depression; Diffusion tensor imaging; Fabry disease; Magnetic resonance imaging; Neuropsychology

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COGNITION; DEPRESSION; DIFFUSION TENSOR IMAGING; DISEASE SEVERITY; FABRY DISEASE; FEMALE; HUMAN; LEARNING DISORDER; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MEMORY DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; STROKE; WHITE MATTER;

ADULT; BRAIN; COGNITION; COGNITION DISORDERS; DEPRESSION; FABRY DISEASE; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEUROPSYCHOLOGICAL TESTS; PSYCHOTIC DISORDERS;

EID: 78751547511     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2010.03155.x     Document Type: Article

References (40)

1. Zarate YA, Hopkin RJ. Lysosomal storage disease 3: Fabry's disease. Lancet 2008; 372: 1427-1435.
2. Fellgiebel A, Muller MJ, Ginsberg L. CNS manifestations of Fabry's disease. Lancet Neurol 2006; 5: 791-795.
3. Fellgiebel A, Keller I, Marin D, et al. Diagnostic utility of different MRI and MR angiography measures in Fabry disease. Neurol 2009; 72: 63-68.
4. Albrecht J, Dellani PR, Muller MJ, et al. Voxel based analyses of diffusion tensor imaging in Fabry disease. J Neurol Neurosurg Psychiatry 2007; 78: 964-969.
5. Kaye EM, Kolodny EH, Logigian EL, Ullman MD. Nervous system involvement in Fabry's disease: clinicopathological and biochemical correlation. Ann Neurol 1988; 23: 505-509.
6. Mendez MF, Stanley TM, Medel NM, Li Z, Tedesco DT. The vascular dementia of Fabry's disease. Dement Geriatr Cogn Disord 1997; 8: 252-257.
7. Mohanraj R, Leach JP, Broome JC, Smith DF. Neurological presentation of Fabry's disease in a 52 year old man. J Neurol Neurosurg Psychiatry 2002; 73: 340-342.
8. Grewal RP. Psychiatric disorders in patients with Fabry's disease. Int J Psychiatry Med 1993; 23: 307-312.
9. Müller MJ, Müller KM, Dascalescu A, et al. [Psychiatric and neuropsychological signs and symptoms in patients with fabry disease: literature review]. Fortschr Neurol Psychiatr 2005; 73: 687-693.
10. Ginsberg L, Valentine A, Mehta A. Fabry disease. Pract Neurol 2005; 5: 110-113.
11. Low M, Nicholls K, Tubridy N, et al. Neurology of Fabry disease. J Intern Med 2007; 37: 436-447.
12. MacDermot KD, Holmes A, Miners AH. Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males. J Med Genet 2001; 38: 750-760.
13. Sadek J, Shellhaas R, Camfield CS, Camfield PR, Burley J. Psychiatric findings in four female carriers of Fabry disease. Psychiatr Genet 2004; 14: 199-201.
14. Cole AL, Lee PJ, Hughes DA, Deegan PB, Waldek S, Lachmann RH. Depression in adults with Fabry disease: a common and under-diagnosed problem. J Inherit Metab Dis 2007; 30: 943-951.
15. Laney DA, Gruskin DJ, Fernhoff PM, et al. Social-adaptive and psychological functioning of patients affected by Fabry disease. J Inherit Metab Dis 2010; DOI: [Epub ahead of print].
16. Crosbie TW, Packman W, Packman S. Psychological aspects of patients with Fabry disease. J Inherit Metab Dis 2009; 32: 745-753.
17. Liston EH, Levine MD, Philippart M. Psychosis in Fabry disease and treatment with phenoxybenzamine. Arch Gen Psychiatry 1973; 29: 402-403.
18. Shen YC, Haw-Ming L, Lin CC, Chen CH. Psychosis in a patient with Fabry's disease and treatment with aripiprazole. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31: 779-780.
19. Desnick RJ, Brady R, Barranger J, et al. Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Inter Med 2003; 138: 338-346.
20. Whybra C, Kampmann C, Krummenauer F, et al. The mainz severity score index: a new instrument for quantifying the Anderson-Fabry disease phenotype, and the response of patients to enzyme replacement therapy. Clin Genet 2004; 65: 299-307.
21. Rey A. L'examen Clinique En Psychologie. Paris, France: Presses Universitaires de France, 1964.
22. Härting C, Markowitsch HJ, Neufeld H, Calabrese P, Deisinger K, Kessler J. Wechsler Gedächtnistest - Revidierte Fassung (WMS-R). Bern: Huber Verlag, 2000.
23. Zimmermann P, Fimm B. Testbatterie zur Aufmerksamkeitsprüfung (TAP). Version 1.7. Freiburg: Psytest, 2002.
24. Kortte KB, Horner MD, Windham WK. The trail making test, part B: cognitive flexibility or ability to maintain set? Appl Neuropsychol 2002; 9: 106-109.
25. Heaton RK, Chelune GJ, Talley JL, Kay GG, Curtiss G. Wisconsin Card Sorting Test Manual. Revised and expanded. Odessa, Florida: Psychological Assessment Resources, 1993.
26. Hamilton M. The hamilton rating scale for depression. In: Sartorius N, Ban TA, eds. Assessment of Depression. Berlin: Springer Verlag, 1986: 143-152.
27. Kay SR, Opler LA, Fiszbein A. Positive and Negative Syndrome Scale (PANSS). Manual. North Tonawanda, NY: Multi-Health Systems, 1999.
28. Radbruch L, Loick G, Kiencke P, et al. Validation of the German version of the brief pain inventory. J Pain Symptom Manage 1999; 18: 180-187.
29. Bullinger M, Kirchberger I. SF-36. Fragebogen zum Gesundheitszustand. Handanweisung. Göttingen: Hogrefe Verlag, 1998.
30. Kretschmann WJ, Weinrich W. Klinische Neuroanatomie und kranielle Bilddiagnostik, 2nd edn. Stuttgart, New York: Thieme Verlag, 1991.
31. Stojanovich L, Zandman-Goddard G, Pavlovich S, Sikanich N. Psychiatric manifestations in systemic lupus erythematosus. Autoimmun Rev 2007; 6: 421-426.
32. Kozora E, Arciniegas DB, Zhang L, West S. Neuropsychological patterns in systemic lupus erythematosus patients with depression. Arthritis Res Ther 2007; 9: R48.
33. Hanly JG, Harrison MJ. Management of neuropsychiatric lupus. Best Pract Res Clin Rheumatol 2005; 19: 799-821.
34. Garcia-Cebrian A, Gandhi P, Demyttenaere K, Peveler R. The association of depression and painful physical symptoms-a review of the European literature. Eur Psychiatry 2006; 21: 379-388.
35. Delano-Wood L, Abeles N, Sacco JM, Wierenga CE, Horne NR, Bozoki A. Regional white matter pathology in mild cognitive impairment: differential influence of lesion type on neuropsychological functioning. Stroke 2008; 39: 794-799.
36. Schmidt R, Petrovic K, Ropele S, Enzinger C, Fazekas F. Progression of leukoaraiosis and cognition. Stroke 2007; 38: 2619-2625.
37. Tektonidou MG, Varsou N, Kotoulas G, Antoniou A, Moutsopoulos HM. Cognitive deficits in patients with antiphospholipid syndrome: association with clinical, laboratory, and brain magnetic resonance imaging findings. Arch Intern Med 2006; 166: 2278-2284.
38. Godin O, Dufouil C, Maillard P, et al. White matter lesions as a predictor of depression in the elderly: the 3C-Dijon study. Biol Psychiatry 2008; 63: 663-669.
39. Bisschop MI, Kriegsman DM, Beekman AT, Deeg DJ. Chronic diseases and depression: the modifying role of psychosocial resources. Soc Sci Med 2004; 59: 721-733.
40. Gunning-Dixon FM, Raz N. The cognitive correlates of white matter abnormalities in normal aging: a quantitative review. Neuropsychol 2000; 14: 224-232.